Treatment of muscular contraction deformities with botulinum toxin type A after latissimus dorsi flap and sub-pectoral implant breast reconstruction.
Abstract
Unusual and probably underestimated complications following breast reconstruction with a latissimus dorsi (LD) flap and sub-pectoral implant are the LD muscle twitching and the breast contour deformities from pectoralis major (PM) muscle contraction. Surgical muscle denervation is usually indicated for these complications. Botulinum toxin A (BTX-A) infiltration has been described in reducing breast contour deformity in sub-pectoral implant after breast augmentation or reconstruction. Between January 2002 and April 2006, 71 consecutive patients underwent delayed unilateral breast reconstructions with LD flap and sub-pectoral implant after mastectomy. All patients reporting discomforting signs and symptoms from muscle contraction in the reconstructed breast were included in this prospective study. Thirteen patients (18.3%) were selected and treated with BTX-A percutaneous local injections. Signs and symptoms were evaluated, after 4, 8 and 12 months, by the patients and by a panel of three physicians not involved in the study, using a five-point scale. During the study period all patients reported a decrease or disappearance of the signs and symptoms. After 12 months, 11 patients received three BTX-A infiltrations, demonstrating considerable improvements compared to the pre-treatment status. Wilcoxon matched pairs rank sum test showed a statistical difference between pre-treatment and post-treatment scores after 14 days (P<0.01) and 12 months (P<0.001). Our experience shows that muscular contraction deformities after breast reconstruction with a LD flap plus implant are not uncommon complications. The use of BTX-A infiltrations is an effective, not surgical, low cost and low risk procedure to treat these complications. It is an easy procedure to be performed on an outpatient basis with a temporary effect but safely repeatable and reproducible; it avoids hospitalisation or further surgical procedures and demonstrates tolerable latency with satisfactory outcomes.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 8 | |
| 시술 | flap
|
피판재건술 | dict | 3 | |
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 시술 | breast augmentation
|
유방성형술 | dict | 1 | |
| 시술 | latissimus dorsi flap
|
피판재건술 | dict | 1 | |
| 해부 | muscular
|
scispacy | 1 | ||
| 해부 | latissimus dorsi
|
scispacy | 1 | ||
| 해부 | muscle
|
scispacy | 1 | ||
| 해부 | pectoralis
|
scispacy | 1 | ||
| 합병증 | sub-pectoral implant breast
|
scispacy | 1 | ||
| 합병증 | sub-pectoral implant
|
scispacy | 1 | ||
| 약물 | BTX-A
→ Botulinum toxin A
|
scispacy | 1 | ||
| 질환 | muscular contraction deformities
|
scispacy | 1 | ||
| 질환 | muscle twitching
|
C0015644
Muscular fasciculation
|
scispacy | 1 | |
| 질환 | muscle contraction
|
C0026820
Muscle Contraction
|
scispacy | 1 | |
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | sub-pectoral
|
scispacy | 1 | ||
| 기타 | BTX-A infiltrations
|
scispacy | 1 |
MeSH Terms
Adult; Botulinum Toxins, Type A; Breast Neoplasms; Contracture; Esthetics; Female; Humans; Mammaplasty; Mastectomy; Middle Aged; Neuromuscular Agents; Patient Satisfaction; Postoperative Complications; Prospective Studies; Surgical Flaps; Treatment Outcome
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.